1105 related articles for article (PubMed ID: 25538312)
1. Insights into the role of the microbiome in obesity and type 2 diabetes.
Hartstra AV; Bouter KE; Bäckhed F; Nieuwdorp M
Diabetes Care; 2015 Jan; 38(1):159-65. PubMed ID: 25538312
[TBL] [Abstract][Full Text] [Related]
2. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota and type 2 diabetes mellitus.
Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
5. Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition.
Kootte RS; Levin E; Salojärvi J; Smits LP; Hartstra AV; Udayappan SD; Hermes G; Bouter KE; Koopen AM; Holst JJ; Knop FK; Blaak EE; Zhao J; Smidt H; Harms AC; Hankemeijer T; Bergman JJGHM; Romijn HA; Schaap FG; Olde Damink SWM; Ackermans MT; Dallinga-Thie GM; Zoetendal E; de Vos WM; Serlie MJ; Stroes ESG; Groen AK; Nieuwdorp M
Cell Metab; 2017 Oct; 26(4):611-619.e6. PubMed ID: 28978426
[TBL] [Abstract][Full Text] [Related]
6. [Microbiota and obesity].
Karney A
Dev Period Med; 2017; 21(3):203-207. PubMed ID: 29077559
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota and obesity: implications for fecal microbiota transplantation therapy.
Kang Y; Cai Y
Hormones (Athens); 2017 Jul; 16(3):223-234. PubMed ID: 29278509
[TBL] [Abstract][Full Text] [Related]
8. Fecal microbiota transplantation in metabolic syndrome: History, present and future.
de Groot PF; Frissen MN; de Clercq NC; Nieuwdorp M
Gut Microbes; 2017 May; 8(3):253-267. PubMed ID: 28609252
[TBL] [Abstract][Full Text] [Related]
9. Microbiota and diabetes: an evolving relationship.
Tilg H; Moschen AR
Gut; 2014 Sep; 63(9):1513-21. PubMed ID: 24833634
[TBL] [Abstract][Full Text] [Related]
10. Gut-Specific Delivery of T-Helper 17 Cells Reduces Obesity and Insulin Resistance in Mice.
Hong CP; Park A; Yang BG; Yun CH; Kwak MJ; Lee GW; Kim JH; Jang MS; Lee EJ; Jeun EJ; You G; Kim KS; Choi Y; Park JH; Hwang D; Im SH; Kim JF; Kim YK; Seoh JY; Surh CD; Kim YM; Jang MH
Gastroenterology; 2017 Jun; 152(8):1998-2010. PubMed ID: 28246016
[TBL] [Abstract][Full Text] [Related]
11. Treating Obesity and Metabolic Syndrome with Fecal Microbiota Transplantation.
Marotz CA; Zarrinpar A
Yale J Biol Med; 2016 Sep; 89(3):383-388. PubMed ID: 27698622
[TBL] [Abstract][Full Text] [Related]
12. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome.
Xiao S; Fei N; Pang X; Shen J; Wang L; Zhang B; Zhang M; Zhang X; Zhang C; Li M; Sun L; Xue Z; Wang J; Feng J; Yan F; Zhao N; Liu J; Long W; Zhao L
FEMS Microbiol Ecol; 2014 Feb; 87(2):357-67. PubMed ID: 24117923
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota, obesity and metabolic disorders.
Federico A; Dallio M; DI Sarno R; Giorgio V; Miele L
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):337-344. PubMed ID: 28927249
[TBL] [Abstract][Full Text] [Related]
14. Infusion of donor feces affects the gut-brain axis in humans with metabolic syndrome.
Hartstra AV; Schüppel V; Imangaliyev S; Schrantee A; Prodan A; Collard D; Levin E; Dallinga-Thie G; Ackermans MT; Winkelmeijer M; Havik SR; Metwaly A; Lagkouvardos I; Nier A; Bergheim I; Heikenwalder M; Dunkel A; Nederveen AJ; Liebisch G; Mancano G; Claus SP; Benítez-Páez A; la Fleur SE; Bergman JJ; Gerdes V; Sanz Y; Booij J; Kemper E; Groen AK; Serlie MJ; Haller D; Nieuwdorp M
Mol Metab; 2020 Dec; 42():101076. PubMed ID: 32916306
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota and Energy Expenditure in Health and Obesity.
Bakker GJ; Zhao J; Herrema H; Nieuwdorp M
J Clin Gastroenterol; 2015; 49 Suppl 1():S13-9. PubMed ID: 26447957
[TBL] [Abstract][Full Text] [Related]
16. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.
Remely M; Aumueller E; Merold C; Dworzak S; Hippe B; Zanner J; Pointner A; Brath H; Haslberger AG
Gene; 2014 Mar; 537(1):85-92. PubMed ID: 24325907
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
Esteve E; Ricart W; Fernández-Real JM
Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
[TBL] [Abstract][Full Text] [Related]
18. Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.
Han JL; Lin HL
World J Gastroenterol; 2014 Dec; 20(47):17737-45. PubMed ID: 25548472
[TBL] [Abstract][Full Text] [Related]
19. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.
Cani PD; Bibiloni R; Knauf C; Waget A; Neyrinck AM; Delzenne NM; Burcelin R
Diabetes; 2008 Jun; 57(6):1470-81. PubMed ID: 18305141
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
